These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34722212)

  • 1. Findings suggestive of coronary microvascular dysfunction in cats with myocardial ischemia.
    Belerenian G; Donati PA; Rodriguez CD; Castillo V; Guevara JM; Pucheta C; Ferraris S; Olivares RWI
    Open Vet J; 2021; 11(3):468-470. PubMed ID: 34722212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.
    Kittleson MD; Côté E
    J Feline Med Surg; 2021 Nov; 23(11):1028-1051. PubMed ID: 34693811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.
    Kittleson MD; Côté E
    J Feline Med Surg; 2021 Nov; 23(11):1053-1067. PubMed ID: 34693805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells.
    Rodríguez JMM; Fonfara S; Hetzel U; Kipar A
    Vet Pathol; 2022 Mar; 59(2):269-283. PubMed ID: 34955067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of myocardial dysfunction in a cat that gradually progressed to endomyocardial form of restrictive cardiomyopathy.
    Saito T; Suzuki R; Yuchi Y; Teshima T; Matsumoto H; Koyama H
    BMC Vet Res; 2021 Aug; 17(1):274. PubMed ID: 34391430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
    Cecchi F; Sgalambro A; Baldi M; Sotgia B; Antoniucci D; Camici PG; Sciagrà R; Olivotto I
    J Cardiovasc Transl Res; 2009 Dec; 2(4):452-61. PubMed ID: 20560003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomography.
    Wieneke H; Zander C; Eising EG; Haude M; Bockisch A; Erbel R
    Herz; 1999 Nov; 24(7):515-21. PubMed ID: 10609157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy.
    Khor KH; Campbell FE; Owen H; Shiels IA; Mills PC
    Vet J; 2015 Feb; 203(2):161-8. PubMed ID: 25573453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy.
    Cesta MF; Baty CJ; Keene BW; Smoak IW; Malarkey DE
    Vet Pathol; 2005 Jul; 42(4):458-67. PubMed ID: 16006605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic alterations in hypertrophic and congestive cardiomyopathy of cats.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Vet Res; 1980 Dec; 41(12):2037-48. PubMed ID: 7194009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.
    Suzuki R; Mochizuki Y; Yoshimatsu H; Niina A; Teshima T; Matsumoto H; Koyama H
    J Vet Intern Med; 2019 Jan; 33(1):37-45. PubMed ID: 30499128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences.
    Olivotto I; Cecchi F; Camici PG
    Ital Heart J; 2004 Aug; 5(8):572-80. PubMed ID: 15554027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of feline myocardial fibrosis.
    Aupperle H; Baldauf K; März I
    J Comp Pathol; 2011; 145(2-3):158-73. PubMed ID: 21324471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of primary myocardial diseases.
    Liu SK; Tilley LP
    Yale J Biol Med; 1980; 53(3):191-211. PubMed ID: 6447412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Feline Cardiomyopathies: 1. General concepts.
    Kittleson MD; Côté E
    J Feline Med Surg; 2021 Nov; 23(11):1009-1027. PubMed ID: 34693806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy in man and cats.
    Maron BJ; Fox PR
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S6-9. PubMed ID: 26776595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular Dysfunction in Hypertrophic Cardiomyopathy.
    Pelliccia F; Cecchi F; Olivotto I; Camici PG
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour ambulatory (Holter) electrocardiographic findings in 13 cats with non-hypertrophic cardiomyopathy.
    Ferasin L; Ferasin H; Borgeat K
    Vet J; 2020 Oct; 264():105537. PubMed ID: 33012440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.